Dr. Ariadna Mendoza-Naranjo
Biochemistry La Havana University, Cuba
PhD Biomedical Sciences, University of Chile


• Mendoza-Naranjo A, Sáez PJ, Johansson C, Ramírez M, Mandakovic D, Pereda C, López M, Kiessling Rolf, Sáez JC, Salazar-Onfray F. “Functional Gap Junctions Facilitate Melanoma Antigen Transfer and Cross-Presentation in Human Dendritic Cells”. J. Immunol. 2007; 178(11).

• Mendoza-Naranjo A, González-Billault C, Maccioni RB. “Aß1-42 Stimulates Actin Polymerization in Hippocampal Neurons through Rac1 and Cdc42 Rho GTPases”. J Cell Sci. 2007; 120(Pt 2):279-88.

• Salazar-Onfray F, López M, Mendoza-Naranjo A. Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev. 2007; 18(1-2):171-82.

• López M, Pereda C, Ramírez M, Mendoza-Naranjo A, Serrano A, Ferreira A, Pobrete R, Kalergis AM, Kiessling R, and Salazar-Onfray F. “Melanocortin 1 Receptor is Expressed by Uveal Malignant Melanoma and can be Considered a New Target for Diagnosis and Immunotherapy”. Invest Ophth Vis Sci 2007; 48(3):1219-27.

• López M, Aguilera R, Pérez R, Mendoza-Naranjo A, Cabrera E, Ferrada C, Aguillón JC, Salazar-Onfray F. “The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines”. Immunobiology. 2006; 211(1-2):127-36.

• Maccioni RB, Lavados M, Maccioni CB and Mendoza-Naranjo A. “Biological Markers of Alzheimer’s Disease and Mild Cognitive Impairment”. Current Alzheimer Research 2004; 1(4):307-314.

• Otth C, Mendoza-Naranjo A, Mujica L, Zambrano A, Concha II, Maccioni RB. “Modulation of the JNK and p38 pathways by Cdk5 protein kinase in a transgenic mouse model” Neuroreport 2003; 14(18):2403-9.